Stay updated on Inhaled Treprostinil in PH-COPD Clinical Trial
Sign up to get notified when there's something new on the Inhaled Treprostinil in PH-COPD Clinical Trial page.

Latest updates to the Inhaled Treprostinil in PH-COPD Clinical Trial page
- Check3 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 with no visible changes to study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoChange DetectedAdded a 'Show glossary' option and standardized metadata labels, including updating to revision v3.4.0; the previous labels and older revision tag were removed.SummaryDifference0.2%

- Check17 days agoChange DetectedAdded a 'Last Update Posted' label and removed the 'Last Update Posted (Estimated)' label from the study record page.SummaryDifference0.0%

- Check25 days agoChange DetectedThe page's revision history shows an addition of Revision v3.3.4 and a deletion of Revision v3.3.3. The change is limited to revision metadata and does not modify study details, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedThe Study Details Locations were updated: new sites across Alabama, California, Florida, Georgia, Illinois, Indiana, Kentucky, Maryland, Massachusetts, Michigan, New York, North Carolina, Ohio, Pennsylvania, South Carolina, Virginia, Wisconsin, plus Forli, Italy, were added and the revision moved from v3.3.2 to v3.3.3.SummaryDifference2%

- Check53 days agoChange DetectedA new study location was added in Forlì, Italy, bringing the total number of locations to 31. The page now lists the Forlì site among study locations.SummaryDifference0.5%

Stay in the know with updates to Inhaled Treprostinil in PH-COPD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in PH-COPD Clinical Trial page.